| Description | CTX-2026, a fully human antibody, targets and binds to CD277, demonstrating an anti-tumor effect in ovarian tumor models, and is utilized in cancer research [1]. |
| In vitro | CTX-2026（1 μg/mL; 12 h）将来自多个供体的Vγ9Vδ2 T细胞的细胞毒性作用重定向至BTN3A1+ OVCAR3细胞或原发性HGSOC细胞[1]。 |
| In vivo | CTX-2026（5 mg/kg；每3天腹腔注射一次，连续15天）对NY-OVCAR3肿瘤小鼠的肿瘤生长有影响[1]。 |
| molecular weight | N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |